Patients undergoing dental treatment under general anesthesia
Conditions
Interventions
Antagonist use group. 5 minutes after the end of surgery, administer 2 ml of flumazenil.
Antagonist non-use group. 5 minutes after the end of surgery, administer 2 ml of physiological saline.
Sponsors
Tokyo dental college
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ASA-PS I or II patients (18-64 years old) scheduled for minimally invasive surgery in the outpatient department of dental anesthesiology.
Exclusion criteria
Exclusion criteria: Those with ASA-PS III or higher, those who have difficulty in securing the airway due to micrognathism, trismus, extreme obesity, etc., those who are thought to have gastric contents, major invasive surgery or long-term treatment, postoperative Cases with expected complications (bleeding or swelling), emergency surgery, patients with infection, those who have difficulty communicating, those with unilateral overgrowth, etc. Persons, persons taking benzodiazepine anxiolytics, persons under the age of 18
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Before anesthesia and 30, 60, 90, 120 minutes after extubation, psychomotor function is examined and compared with Digit Symbol Substitution Test and Trieger dot test, and equilibrium function is examined and compared with Timed Up & Go Test and Center of gravity sway test. Sedation level is assessed using the MOA/S score every minute after administration of flumazenil or saline. | — |
Countries
Japan
Contacts
Public Contactkyotaro koshika
Tokyo dental college Department of Dental Anesthesiology
Outcome results
None listed